Literature DB >> 8925081

Drug-protein binding sites. New trends in analytical and experimental methodology.

J Oravcová1, B Böhs, W Lindner.   

Abstract

In the last few years, continuous progress in instrumental analytical methodology has been achieved with a substantial increase in the number of new, more specific and more flexible methods for ligand-protein assays. In general, the methods used for drug-protein binding studies can be divided into two main groups: separation methods (enabling the calculation of binding parameters, i.e. the number of binding sites and their respective affinity constants) and non-separation methods (describing predominantly qualitative parameters of the ligand-protein complex). This review will be focussed particularly on recent trends in the development of drug-protein binding methods including stereoselective and non-stereoselective aspects using chromatography, capillary electrophoresis and microdialysis as compared to the "conventional approach" using equilibrium dialysis, ultrafiltration or size exclusion chromatography. The advantages and limitations of various methods will be discussed including a focus on "optimal" experimental strategies taking into account in vitro, ex vivo and/or in vivo studies. Furthermore, the importance of some particular aspects concerning the drug binding to proteins (covalent binding of drugs and metabolites, stereoselective interactions and evaluation of binding data) will be outlined in more detail.

Mesh:

Substances:

Year:  1996        PMID: 8925081     DOI: 10.1016/0378-4347(95)00425-4

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  28 in total

1.  The use of in vitro metabolic stability for rapid selection of compounds in early discovery based on their expected hepatic extraction ratios.

Authors:  Yan Yi Lau; Gopal Krishna; Nathan P Yumibe; Diane E Grotz; Elpida Sapidou; Laura Norton; Inhou Chu; Cliff Chen; A D Soares; Chin-Chung Lin
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  A new trend in the experimental methodology for the analysis of the thioflavin T binding to amyloid fibrils.

Authors:  Irina M Kuznetsova; Anna I Sulatskaya; Vladimir N Uversky; Konstantin K Turoverov
Journal:  Mol Neurobiol       Date:  2012-05-17       Impact factor: 5.590

3.  Frontal analysis in microchip CE: a simple and accurate method for determination of protein-DNA dissociation constant.

Authors:  Maojun Gong; Kenneth R Wehmeyer; Patrick A Limbach; William R Heineman
Journal:  Electrophoresis       Date:  2007-03       Impact factor: 3.535

Review 4.  Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.

Authors:  Jürgen Beer; Claudia Christina Wagner; Markus Zeitlinger
Journal:  AAPS J       Date:  2009-01-01       Impact factor: 4.009

5.  Selective detection of specific protein-ligand complexes by electrosonic spray-precursor ion scan tandem mass spectrometry.

Authors:  Noemi Czuczy; Maria Katona; Zoltan Takats
Journal:  J Am Soc Mass Spectrom       Date:  2008-09-18       Impact factor: 3.109

6.  Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice.

Authors:  C L Chen; R Malaviya; C Navara; H Chen; B Bechard; G Mitcheltree; X P Liu; F M Uckun
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

Review 7.  Protein binding: do we ever learn?

Authors:  Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

Review 8.  Capillary electrophoresis in pharmaceutical analysis.

Authors:  L A Holland; N P Chetwyn; M D Perkins; S M Lunte
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

9.  A simple model-free method for direct assessment of fluorescent ligand binding by linear spectral summation.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  J Fluoresc       Date:  2013-09-18       Impact factor: 2.217

10.  Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.

Authors:  Teresa Mairal; Joan Nieto; Marta Pinto; Maria Rosário Almeida; Luis Gales; Alfredo Ballesteros; José Barluenga; Juan J Pérez; Jesús T Vázquez; Nuria B Centeno; Maria Joao Saraiva; Ana M Damas; Antoni Planas; Gemma Arsequell; Gregorio Valencia
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.